| __timestamp | Ionis Pharmaceuticals, Inc. | Mesoblast Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 25434000 |
| Thursday, January 1, 2015 | 322292000 | 23783000 |
| Friday, January 1, 2016 | 344320000 | 29763000 |
| Sunday, January 1, 2017 | 374644000 | 12065000 |
| Monday, January 1, 2018 | 1820000 | 5508000 |
| Tuesday, January 1, 2019 | 4000000 | 75173000 |
| Wednesday, January 1, 2020 | 12000000 | 81497000 |
| Friday, January 1, 2021 | 11000000 | 85731000 |
| Saturday, January 1, 2022 | 14000000 | 63572000 |
| Sunday, January 1, 2023 | 9133000 | 54922000 |
| Monday, January 1, 2024 | 11215000 | 41070000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Ionis Pharmaceuticals, Inc. and Mesoblast Limited have shown contrasting trends in their cost of revenue. Ionis Pharmaceuticals experienced a significant peak in 2017, with costs reaching nearly 375 million, before a dramatic drop in 2018. This fluctuation highlights the volatile nature of pharmaceutical operations. In contrast, Mesoblast Limited's cost of revenue steadily increased, peaking in 2021 with a 237% rise from 2014. This consistent growth suggests a strategic expansion or increased production capacity. Notably, 2024 data for Ionis Pharmaceuticals is missing, indicating potential reporting delays or strategic shifts. These insights underscore the importance of cost management in maintaining competitive advantage in the pharmaceutical sector.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.
Zoetis Inc. vs Mesoblast Limited: Efficiency in Cost of Revenue Explored
Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down GSK plc and Mesoblast Limited's Expenses
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Ionis Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Mesoblast Limited
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Vericel Corporation
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Mesoblast Limited
Analyzing Cost of Revenue: Mesoblast Limited and Taro Pharmaceutical Industries Ltd.